The Significance of Lipid Abnormalities in Patients Receiving Dialysis Therapy
Open Access
- 1 August 1983
- journal article
- research article
- Published by SAGE Publications in Peritoneal Dialysis International
- Vol. 3 (3_suppl) , 29-32
- https://doi.org/10.1177/089686088300303s10
Abstract
The accelerated atherosclerosis seen in dialysis patients is multifactorial in origin. Abnormalities in lipid metabolism probably contribute to this premature vascular disease. Despite attempts to modify these abnormalities by dietary modifications, change in dialysis modalities, drug therapy and more recently exercise, the ideal approach has not yet been determined.Keywords
This publication has 7 references indexed in Scilit:
- Increased Lipoprotein-Remnant Formation in Chronic Renal FailureNew England Journal of Medicine, 1982
- The metabolic and psychological effects of exercise training in hemodialysis patientsThe American Journal of Clinical Nutrition, 1980
- Increase in Lipoprotein Lipase during Clofibrate Treatment of Hypertriglyceridemia in Patients on HemodialysisNew England Journal of Medicine, 1979
- Plasma High-Density Lipoprotein Concentrations in Chronic-Hemodialysis and Renal-Transplant PatientsNew England Journal of Medicine, 1977
- Defective Triglyceride Removal in Lipemia Associated with Peritoneal Dialysis and HaemodialysisAnnals of Internal Medicine, 1976
- HypertriglyceridemiaNew England Journal of Medicine, 1968
- Evaluation of Serum Lipoprotein and Cholesterol Measurements as Predictors of Clinical Complications of AtherosclerosisCirculation, 1956